named matthew as merrick, could rule on a case that seeks to upend access to a key component of medication abortion nationwide. that is a drug called the fda approved for use in september of 2000, and since then, it has been used safely by about 5 million people in the united states alone. typically, in tandem with another truck called now, works mifepristone by blocking the production of a hormone that s needed for pregnancy. and then it begins a miscarriage, and the two drugs when used together, they re about 99.6% effective at terminating a pregnancy or completing a miscarriage and they are safe. if you don t want to take the word of the 5 million people in america have taken that drug, you can look into decades of research that show the risk of complications that mifepristone is less than 0.4%. that basically means that it is safer than tylenol and viagra. it is so safe, in fact, about as of 2022, more than 54% of abortions in the united states happened with these pil
those drugs could be on the chopping block, courtesy of a texas court, where a trump appointed u.s. district judge, named matthew kacsmaryk, could rule on a case that seeks to upend access to a key component of medication abortion nationwide. that component is a drug called mifepristone. the fda approved it for use in september of 2000, and since then, it has been used safely by about 5 million people in the united states alone. typically, in tandem with another drug called misoprostol. now, mifepristone works by blocking the production of a hormone that s needed for pregnancy. misoprostol then begins a miscarriage. and the two drugs, when used together, they re about 99. 6% effective at terminating a pregnancy or completing a miscarriage, and they are safe. if you don t want to take the word of the 5 million people in america who have taken that pale, you can look into decades of research that show the risk of complications that mifepristone is less than 0. 4%. that basicall
impeached? it s way too early for this. good morning! and welcome to way too early, the show that sends big props to all the tech folks behind the scenes here who had a very busy start to their day at 30 rock. thank you, guys, for getting us on the air this morning. i am kasie hunt on this thursday, march 11th. we will start with the news. in a major legislative win for president biden, the house passed the massive $1.9 trillion coronavirus relief bill. the final vote was 220-211, mostly along party lines. one democrat, congressman jared golden of maine, joined all republicans in voting against the bill. democrats erupted in applause after the roll call. on this vote, the yeas are 220, the nays are 211. the motion is adopted. the white house also posted this video of president biden and vice president kamala harris applauding as the bill was passed. president biden said he ll sign it tomorrow. this bill represents an historic, historic victory for the american peo
because mark is that right? there are these 12 blue states that have filed this lawsuit also against the fda and they re seeking to remove the risk evaluation and mitigation strategies that apply to mifepristone, that apply to only a handful drugs, mifepristone being one of them. and the idea here is that it will make mifepristone more accessible to individuals, if those mitigation protocols are removed. but they have also asked for various legal remedies that would basically blunt anything that the judge might do in the texas lawsuit. so, they also asked for the court to declare the fda s approval of mifepristone to be lawful and confirmed. and they have also asked the fda to adjoin any measures to limit the supply of mifepristone to those who may need it. so, adding these additional elements in their lawsuits that in addition to making this more accessible would also block the force of this, and perhaps predate a kind of slough split
is that what we are talking about here? they are hoping for a split court decision to then sort of complicate the landscape, at least as it concerns judge because mark? is that right. there are these 12 blue states that have filed this lawsuit also against the fda and they re seeking to remove the risk evaluation and mitigation strategies that apply to mifepristone, that apply to only a handful drugs, mifepristone being one of them. and the idea here is that it will make mifepristone more accessible to individuals, if those mitigation protocols are removed. but they have also asked for various legal remedies that would basically blunt anything that the judge might do in the texas lawsuit. so, they also asked for the court to declare the fda s approval of mifepristone to be lawful and confirmed. and they have also asked the fda to adjoin any measures to limit the supply of mifepristone to those who may need it. so, adding these additional elements in their lawsuits that in addition to